The global cough remedies market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The market growth is majorly attributed to the growing prevalence of cough and flu all over the globe. According to the World Health Organization, it is estimated that 2.5 million people were suffering from cold and about 61,000 people died from the flu in 2019 all over the globe. Further, switch from prescription to OTC category, a rise in the rise geriatric population, and demand for effective combination products are anticipated to drive the market. However, competition faced by international players due to drugs from local manufacturers and natural remedies restrain the market growth. Favorable regulations and opportunities in the emerging economies of Asia-Pacific and Latin America Middle East and Africa due to availability of large patient pools provide promising growth opportunities for the market. 

Apart from the major symptom of flu, some other common causes of cough include asthma, COPD, consumption of tobacco, postnasal drip, and Gastroesophageal reflux disease (GERD). Numerous types of conditions are susceptible to cause chronic cough if not treated properly. Major signs and symptoms include frequent throat clearing & sore throat, runny or stuffy nose, hoarseness, wheezing, and shortness of breath. Other causes of cough include chronic obstructive pulmonary disease (COPD), pneumonia, bronchiectasis, nonasthmatic eosinophilic bronchitis bronchiolitis, lung cancer, idiopathic pulmonary fibrosis, and usage of blood pressure drugs. Further, the outbreak of COVID-19 had also boosted the sale of various cough related medications and syrups. In addition, the growth in geriatric population, which is more prone to cough and cold, surge in demand for over-the-counter products. Apart from these factors, increase in vehicle pollution, and growth in the development of R&D activities, among other factors are anticipated to propel the global cough remedies market during the forecast period. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Product Type

o By Dosage Form

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Pfizer Inc., Johnson & Johnson Services, Inc., and GlaxoSmithKline plc, among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Cough Remedies Market Report by Segment

By Product Type

    • Antihistamine

    • Expectorant

    • Bronchodilator

    • Decongestant

    • Antibiotic

By Dosage Form

    • Oral Syrup

    • Tablet/Pills

    • Nasal Drops

    • Lozenge

By End-User

    • Retail

    • Hospitality

    • Sports and Entertainment

    • Transportation

    • Smart Infrastructure

    • Others

Global Cough Remedies Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa